Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ragwitek Safety in Adults 50+ with Ragweed Allergy
NCT00978029Phase 2Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2009
- Primary completion
- Feb 2010
01
Overview
A Phase 2 trial of SQ SLIT-tablet in ragweed-induced allergic rhinoconjunctivitis, sponsored by ALK-Abelló. Started Nov 2009; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
ragweed-induced allergic rhinoconjunctivitis
Beyond the preview
Go deeper on NCT00978029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978029.